Well I can only think management is doubling down on the immunology results due in q3. They can't conceivably continue the current business in this way with the cash burn.
I am amazed by the staffing costs. That's insane. Rough estimate but the people on the ground aren't covering their pay.
Northern credit raising I feel is inevitable and back to penny stocks we go.
I still feel that a larger partner in the regenerative portfolio is required, perhaps indication. Might help alleviate the high staffing costs.
Well I can only think management is doubling down on the...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.52 |
Change
-0.190(1.21%) |
Mkt cap ! $301.9M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.75 | $15.52 | $18.09K | 1.157K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 276 | $15.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.91 | 232 | 5 |
View Market Depth
| Last trade - 11.42am 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |